Key result
The APOA5 rs662799 minor C allele significantly reduced HDL cholesterol (β = -2.048, P < 0.001) and elevated triglycerides (β = 0.053, P < 0.001) in Korean adults.
Why the study?
This study aimed to test the association between APOA5 3'-UTR variants (rs662799) and cardiometabolic traits in Koreans.
Is the APOA5 rs662799 (-1131T>C) genetic polymorphism associated with cardiometabolic traits (specifically circulating HDL cholesterol and triglyceride levels) and APOA5 mRNA expression in Korean adults?
Cross-Sectional (n=9,939)
Yes
Is the APOA5 rs662799 (-1131T>C) genetic polymorphism associated with cardiometabolic traits (specifically circulating HDL cholesterol and triglyceride levels) and APOA5 mRNA expression in Korean adults?
Confirms in two large Korean cohorts that the APOA5 rs662799 minor C allele is strongly associated with higher triglycerides and lower HDL cholesterol without altering APOA5 mRNA abundance, pointing toward post-transcriptional regulation.
Answers are grounded in this paper and cite their sources.
No change to lipid management indicated; leaves open effects on cardiovascular outcomes and mechanisms in Koreans.
BACKGROUND/OBJECTIVES:This study aimed to test the association between APOA5 3'-UTR variants (rs662799) and cardiometabolic traits in Koreans.SUBJECTS/METHODS: For this study, epidemiological data, Apolipoprotein A5 (APOA5) genotype information, and lymphoblastoid cell line (LCL) biospecimens from a subset of the Ansung-Ansan cohort within the Korean Genome and Epidemiology study (KoGES-ASAS; n = 7,704) as well as epidemiological data along with genomic DNA biospecimens of participants from a subset of the Korea National Health and Nutrition Examination Survey (KNHANES 2011-12; n = 2,235) were obtained.APOA5 mRNA expression was also measured.RESULTS: APOA5 rs662799 genotype distributions in both the KoGES-ASAS and KNHANES groups were 50.6% for TT, 41.3% for TC, and 8.1% for CC, which are similar to those in previous reports.In both groups, minor C allele carriers, particularly subjects with CC homozygosity, had lower high-density lipoprotein (HDL) cholesterol and higher triglyceride levels than TT homozygotes.Linear regression analysis showed that the minor C allele significantly contributed to reduction of circulating HDL cholesterol levels [β = -2.048,P < 0.001; β = -2.199,P < 0.001] as well as elevation of circulating triglyceride levels [β = 0.053, P < 0.001; β = 0.066, P < 0.001] in both the KoGES-ASAS and KNHANES groups.In addition, higher expression levels of APOA5 in LCLs of 64 healthy individuals were negatively associated with body mass index (r = -0.277,P = 0.027) and circulating triglyceride level (r = -0.340,P = 0.006) but not significantly correlated with circulating HDL cholesterol level.On the other hand, we observed no significant difference in the mRNA level of APOA5 according to APOA5 rs662799 polymorphisms.CONCLUSIONS: The C allele of APOA5 rs662799 was found to be significantly associated with cardiometabolic traits in a large Korean population from the KoGES-ASAS and KNHANES.The effect of this genotype may be associated with post-transcriptional regulation, which deserves further experimental confirmation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) conducted a cross-sectional in Cardiometabolic traits (dyslipidemia: HDL cholesterol and triglyceride levels) in healthy Korean adults (n=9,939). APOA5 rs662799 (-1131T>C) minor C allele (TC and CC genotypes) vs. APOA5 rs662799 TT homozygotes was evaluated on Circulating high-density lipoprotein (HDL) cholesterol levels (mg/dL) in KoGES-ASAS (beta -2.048, 95% CI -2.398 to -1.699, p=< 0.001). The APOA5 rs662799 minor C allele significantly reduced HDL cholesterol (β = -2.048, P < 0.001) and elevated triglycerides (β = 0.053, P < 0.001) in Korean adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: